EVAR与FEVAR腹主动脉瘤隔绝术后24个月肾脏体积变化
FEVAR组肾脏体积显著下降(182→158.9 mL,P=0.007),EVAR组无显著变化;两组eGFR均无显著下降。
要点
- FEVAR术后24个月肾脏体积显著下降,但eGFR未同步下降。
- EVAR术后24个月肾脏体积和eGFR均无显著变化。
- 肾脏体积下降可能反映肾灌注改变,需长期随访验证。
核心结论
- FEVAR术后24个月肾脏体积显著下降,但eGFR无显著下降,可能反映肾灌注变化并预测长期肾功能损害。
研究设计与样本
- 回顾性单中心研究,来自前瞻性注册数据库,纳入2015至2021年间60至80岁、术前eGFR≥60 ml/min/1.73 m-2且接受EVAR或FEVAR并有24个月CT扫描的患者。
主要发现
- FEVAR组24个月肾脏体积从182 ± 37.8 mL降至158.9 ± 40.2 mL(P=0.007),eGFR从84.1 ± 17.2降至73.8 ± 21.4 ml/min/1.73 m-2(P=0.09)。
- EVAR组24个月eGFR(84.1 ± 17.2 vs. 81 ± 16.2 ml/min/1.73 m-2,P=0.36)和肾脏体积(170.9 ± 29.7 vs. 165.3 ± 37.4 mL,P=0.12)均无显著变化。
临床怎么用
- FEVAR术后应关注肾脏体积变化,即使eGFR稳定,也需长期监测肾功能。
局限性
- 样本量小,无法确认肾脏体积下降对长期肾功能损害的预测价值,需进一步长期随访研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Decreased kidney volume is a sign of renal aging and/or decreased vascularization. The aim of this study was to determine whether renal volume changes 24 months after exclusion of an abdominal aortic aneurysm (AAA) and to compare fenestrated (FEVAR) and infrarenal (EVAR) endovascular repair. METHODS: Retrospective single-center study from a prospective registry, including patients between 60 and 80 years with normal preoperative renal function (estimated glomerular filtration rate [eGFR] ≥ 60 ml/min/1.73 m-2) who underwent fenestrated (FEVAR) or infrarenal (EVAR) stent grafts between 2015 and 2021. Patients had to have had a computed tomography scan at 24 months of the study to be included. Exclusion criteria were renal branches, the presence of preoperative renal insufficiency, a single kidney, embolization or coverage of an accessory renal artery, occlusion of a renal artery during follow-up, and mention of AAA rupture. Renal volume was measured using sizing software (EndoSize, therenva) based on fully automatic deep-learning segmentation of several anatomical structures (arterial lumen, bone structure, thrombus, heart, etc.), including the kidneys. In the presence of renal cysts, these were manually excluded from the segmentation. RESULTS: Forty-eight patients were included (24 EVAR vs. 24 FEVAR), 96 kidneys were segmented. There was no difference between groups in age (78.9 ± 6.7 years vs. 69.4 ± 6.8, P = 0.89), eGFR 85.8 ± 12.4 [62-107] ml/min/1.73 m-2 vs. 81 ± 16.2 [42-107] (P = 0.36), and renal volume 170.9 ± 29.7 [123-276] mL vs. 165.3 ± 37.4 [115-298] (P = 0.12). At 24 months in the EVAR group, there was a nonsignificant reduction in eGFR 84.1 ± 17.2 [61-128] ml/min/1.73 m-2 vs. 81 ± 16.2 [42-107] (P = 0.36) or renal volume 170.9 ± 29.7 [123-276] mL vs. 165.3 ± 37.4 [115-298] (P = 0.12). In the FEVAR group, at 24 months there was a nonsignificant fall in eGFR 84.1 ± 17.2 [61-128] ml/min/1.73 m-2 vs. 73.8 ± 21.4 [40-110] (P = 0.09), while renal volume decreased significantly 182 ± 37.8 [123-293] mL vs. 158.9 ± 40.2 [45-258] (P = 0.007). CONCLUSION: In this study, there appears to be a significant decrease in renal volume without a drop in eGFR 24 months after fenestrated stenting. This decrease may reflect changes in renal perfusion and could potentially be predictive of long-term renal impairment, although this cannot be confirmed within the limits of this small sample. Further studies with long-term follow-up are needed.
引用
- Saudreau B, Vannier C, Ben Turkia J, et al. Kidney Volume after Endovascular Exclusion of Abdominal Aortic Aneurysms by EVAR and FEVAR. Ann Vasc Surg. 2025. PMID: 40789507. doi:10.1016/j.avsg.2025.08.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。